Activity

Filter

Cancel
Date Panel Item Activity
6 actions
BabyScreen+ newborn screening v0.1934 CYB561 Zornitza Stark Marked gene: CYB561 as ready
BabyScreen+ newborn screening v0.1934 CYB561 Zornitza Stark Gene: cyb561 has been classified as Green List (High Evidence).
BabyScreen+ newborn screening v0.1934 CYB561 Zornitza Stark Classified gene: CYB561 as Green List (high evidence)
BabyScreen+ newborn screening v0.1934 CYB561 Zornitza Stark Gene: cyb561 has been classified as Green List (High Evidence).
BabyScreen+ newborn screening v0.1933 CYB561 Zornitza Stark Tag treatable tag was added to gene: CYB561.
Tag endocrine tag was added to gene: CYB561.
BabyScreen+ newborn screening v0.1933 CYB561 Zornitza Stark gene: CYB561 was added
gene: CYB561 was added to Baby Screen+ newborn screening. Sources: Expert list
Mode of inheritance for gene: CYB561 was set to BIALLELIC, autosomal or pseudoautosomal
Publications for gene: CYB561 were set to 29343526; 31822578
Phenotypes for gene: CYB561 were set to Orthostatic hypotension 2, MIM# 618182
Review for gene: CYB561 was set to GREEN
Added comment: Three families reported.

Severe orthostatic hypotension, recurrent hypoglycemia, and low norepinephrine levels. The disorder has onset in infancy or early childhood.

Treatment: L-threo-3,4-dihydroxyphenylserine (droxidopa)

Non-genetic confirmatory testing: plasma norepinephrine, epinephrine, dopamine
Sources: Expert list